1. Preface
1.1. Report Description
1.1.1. Purpose of the Report
1.1.2. Target Audience
1.1.3. Key Offerings
1.2. Market Segmentation
1.3. Research Methodology
1.3.1. Phase I - Secondary Research
1.3.2. Phase II - Primary Research
1.3.3. Phase III - Expert Panel Review
1.3.4. Assumptions
1.3.5. Approach Adopted
2. Executive Summary
2.1. Market Snapshot: Global Travel Vaccines Market
2.3. Global Travel Vaccines Market, By Type, 2025 (US$ Million)
2.4. Global Travel Vaccines Market, By Geography, 2025 (US$ Million)
2.5. Attractive Investment Proposition by Geography, 2025
3. Travel Vaccines Market: Competitive Analysis
3.1. Market Positioning of Key Travel Vaccines Market Vendors
3.2. Strategies Adopted by Travel Vaccines Market Vendors
4. Travel Vaccines Market: Macro Analysis & Market Dynamics
4.1. Introduction
4.2. Global Travel Vaccines Market Value, 2024 - 2034, (US$ Million)
4.3. Market Dynamics
4.3.1. Market Drivers
4.3.2. Market Restraints
4.3.3. Key Challenges
4.3.4. Key Opportunities
4.4. Impact Analysis of Drivers and Restraints
4.5. Porter's Five Force Model
4.5.1. Supplier Power
4.5.2. Buyer Power
4.5.3. Threat Of Substitutes
4.5.4. Threat Of New Entrants
4.5.5. Competitive Rivalry
4.6. PESTEL Analysis
4.6.1. Political Landscape
4.6.2. Economic Landscape
4.6.3. Social Landscape
4.6.4. Technology Landscape
4.6.5. Environmental Landscape
4.6.6. Legal Landscape
5. Travel Vaccines Market: By Type, 2024-2034, USD (Million)
5.1. Market Overview
5.2. Growth & Revenue Analysis: 2025 Versus 2034
5.3. Market Segmentation
5.3.1. Routine Vaccination
5.3.1.1. Hepatitis B
5.3.1.2. Influenza
5.3.1.3. MMR
5.3.1.4. Tuberculosis
5.3.1.5. Others
5.3.2. Recommended Vaccination
5.3.2.1. Cholera
5.3.2.2. Japanese Encephalitis
5.3.2.3. Diarrhea
5.3.2.4. Yellow Fever
5.3.2.5. Others
5.3.3. Required Vaccination
5.3.3.1. Malaria
5.3.3.2. Ebola
5.3.3.3. Zika
5.3.3.4. Middle East Respiratory Syndrome
5.3.3.5. Others
6. North America Travel Vaccines Market, 2024-2034, USD (Million)
6.1. Market Overview
6.2. Travel Vaccines Market: By Type, 2024-2034, USD (Million)
6.3. Travel Vaccines Market: By Region, 2024-2034, USD (Million)
6.3.1.North America
6.3.1.1. U.S.
6.3.1.1.1. Travel Vaccines Market: By Type, 2024-2034, USD (Million)
6.3.1.2. Canada
6.3.1.2.1. Travel Vaccines Market: By Type, 2024-2034, USD (Million)
6.3.1.3. Rest of North America
6.3.1.3.1. Travel Vaccines Market: By Type, 2024-2034, USD (Million)
7. UK and European Union Travel Vaccines Market, 2024-2034, USD (Million)
7.1. Market Overview
7.2. Travel Vaccines Market: By Type, 2024-2034, USD (Million)
7.3. Travel Vaccines Market: By Region, 2024-2034, USD (Million)
7.3.1.UK and European Union
7.3.1.1. UK
7.3.1.1.1. Travel Vaccines Market: By Type, 2024-2034, USD (Million)
7.3.1.2. Germany
7.3.1.2.1. Travel Vaccines Market: By Type, 2024-2034, USD (Million)
7.3.1.3. Spain
7.3.1.3.1. Travel Vaccines Market: By Type, 2024-2034, USD (Million)
7.3.1.4. Italy
7.3.1.4.1. Travel Vaccines Market: By Type, 2024-2034, USD (Million)
7.3.1.5. France
7.3.1.5.1. Travel Vaccines Market: By Type, 2024-2034, USD (Million)
7.3.1.6. Rest of Europe
7.3.1.6.1. Travel Vaccines Market: By Type, 2024-2034, USD (Million)
8. Asia Pacific Travel Vaccines Market, 2024-2034, USD (Million)
8.1. Market Overview
8.2. Travel Vaccines Market: By Type, 2024-2034, USD (Million)
8.3. Travel Vaccines Market: By Region, 2024-2034, USD (Million)
8.3.1.Asia Pacific
8.3.1.1. China
8.3.1.1.1. Travel Vaccines Market: By Type, 2024-2034, USD (Million)
8.3.1.2. Japan
8.3.1.2.1. Travel Vaccines Market: By Type, 2024-2034, USD (Million)
8.3.1.3. India
8.3.1.3.1. Travel Vaccines Market: By Type, 2024-2034, USD (Million)
8.3.1.4. Australia
8.3.1.4.1. Travel Vaccines Market: By Type, 2024-2034, USD (Million)
8.3.1.5. South Korea
8.3.1.5.1. Travel Vaccines Market: By Type, 2024-2034, USD (Million)
8.3.1.6. Rest of Asia Pacific
8.3.1.6.1. Travel Vaccines Market: By Type, 2024-2034, USD (Million)
9. Latin America Travel Vaccines Market, 2024-2034, USD (Million)
9.1. Market Overview
9.2. Travel Vaccines Market: By Type, 2024-2034, USD (Million)
9.3. Travel Vaccines Market: By Region, 2024-2034, USD (Million)
9.3.1.Latin America
9.3.1.1. Brazil
9.3.1.1.1. Travel Vaccines Market: By Type, 2024-2034, USD (Million)
9.3.1.2. Mexico
9.3.1.2.1. Travel Vaccines Market: By Type, 2024-2034, USD (Million)
9.3.1.3. Rest of Latin America
9.3.1.3.1. Travel Vaccines Market: By Type, 2024-2034, USD (Million)
10. Middle East and Africa Travel Vaccines Market, 2024-2034, USD (Million)
10.1. Market Overview
10.2. Travel Vaccines Market: By Type, 2024-2034, USD (Million)
10.3. Travel Vaccines Market: By Region, 2024-2034, USD (Million)
10.3.1.Middle East and Africa
10.3.1.1. GCC
10.3.1.1.1. Travel Vaccines Market: By Type, 2024-2034, USD (Million)
10.3.1.2. Africa
10.3.1.2.1. Travel Vaccines Market: By Type, 2024-2034, USD (Million)
10.3.1.3. Rest of Middle East and Africa
10.3.1.3.1. Travel Vaccines Market: By Type, 2024-2034, USD (Million)
11. Company Profile
11.1. Baxter AG (Company Overview, Financial Performance, Product Portfolio, Strategic Initiatives)
11.2. Bharat Biotech
11.3. GlaxoSmithkline, Plc.
11.4. Inovio Pharmaceuticals, Inc.
11.5. Merck & Co., Inc.
11.6. Novartis AG
11.7. PaxVax Corporation
11.8. Sanofi Pasteur SA
11.9. Valneva SE
11.10. VBI Vaccines, Inc.
